Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
06/22/2011 | EP2334685A2 Amorphous pemetrexed disodium |
06/22/2011 | EP2334684A1 Pyrazolopyrimidines and their use for the treatment of cns disorders |
06/22/2011 | EP2334683A1 Saturated bicyclic heterocyclic derivatives as smo antagonists |
06/22/2011 | EP2334682A1 Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
06/22/2011 | EP2334681A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
06/22/2011 | EP2334675A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
06/22/2011 | EP2231662B1 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents |
06/22/2011 | EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
06/22/2011 | EP1812004B1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
06/22/2011 | CN1701073B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
06/22/2011 | CN101560206B Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby |
06/22/2011 | CN101463048B Ruthenium complex inducing DNA conformation transition and preparation thereof |
06/22/2011 | CN101175758B Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
06/22/2011 | CN101157591B Method for nitryl rduction to produce amido in compound containing nitryl phenyl |
06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
06/21/2011 | US7964722 Light-driven rotary molecular motors |
06/21/2011 | US7964720 Method of making porphyrins |
06/21/2011 | US7964607 Pyrazolo[3,4-d]pyrimidine compounds |
06/21/2011 | US7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
06/21/2011 | US7964598 ApoE4 domain interaction inhibitors and methods of use thereof |
06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
06/21/2011 | CA2646962C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
06/21/2011 | CA2618682C Viral polymerase inhibitors |
06/21/2011 | CA2591314C Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy |
06/21/2011 | CA2527155C Cationic porphyrin derivatives and uses thereof |
06/18/2011 | CA2724086A1 Pharmaceutical compounds |
06/16/2011 | WO2011071840A1 Inhibitors of diacylglycerol acyltransferase |
06/16/2011 | WO2011071758A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands |
06/16/2011 | WO2011071725A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core |
06/16/2011 | WO2011071716A1 Heterocyclic compounds containing an indole core |
06/16/2011 | WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
06/16/2011 | WO2011071057A1 Pharmaceutical composition for treatment or prevention of alzheimer's disease containing sulfur-containing heterocyclic derivative |
06/16/2011 | WO2011047770A3 Pyrazolopyrimidine derivatives |
06/16/2011 | WO2011042107A3 Materials for organic electroluminescent devices |
06/16/2011 | US20110144335 Pentasil-structure zeolithic material the production and use thereof |
06/16/2011 | US20110144325 Methods and intermediates for the synthesis of porphyrins |
06/16/2011 | US20110144324 Methods and compositions comprising macrocycles |
06/16/2011 | US20110144177 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents |
06/16/2011 | US20110144135 Compounds for Modulating TRPV3 Function |
06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
06/16/2011 | US20110144131 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines |
06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
06/16/2011 | US20110144091 Inhibitors of Diacylglycerol Acyltransferase |
06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
06/16/2011 | US20110143925 Catalysts and methods for catalytic oxidation |
06/16/2011 | US20110142856 Compound containing basic group and use thereof |
06/16/2011 | US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors |
06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
06/16/2011 | US20110140092 Charge transport compositions and electronic devices made with such compositions |
06/16/2011 | CA2783684A1 Inhibitors of diacylglycerol acyltransferase |
06/16/2011 | CA2782409A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands |
06/15/2011 | EP2333004A1 Soluble terminally modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether, varnish, cured product thereof, imide prepreg thereof, and fiber-reinforced laminate having excellent heat resistance |
06/15/2011 | EP2332963A2 Process for preparing macrocyclic compounds |
06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
06/15/2011 | EP2332648A1 Catalyst for degrading lignin, catalyst for degrading aromatic hydrocarbon, and porphyrin |
06/15/2011 | EP2331571A1 Nmda receptor modulators and uses thereof |
06/15/2011 | EP2331547A1 Pyrrolopyrimidine compounds as cdk inhibitors |
06/15/2011 | EP2331546A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
06/15/2011 | EP2331545A2 Improved process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine&new impurities in preparation thereof |
06/15/2011 | EP2331544A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
06/15/2011 | EP2185561B1 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
06/15/2011 | EP1899346B1 Pyrrolotriazine compounds useful as kinase inhibitors |
06/15/2011 | EP1851225B1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists |
06/15/2011 | EP1838718B1 Pyrrolopyrazoles, potent kinase inhibitors |
06/15/2011 | EP1622616B1 Inhibitors of akt activity |
06/15/2011 | EP1578751B1 Pyrrolopyrimidine derivatives |
06/15/2011 | CN1930145B Cycloalkanopyridine derivative |
06/15/2011 | CN102099359A Hepatitis c virus inhibitors |
06/15/2011 | CN102099357A Carboxamide compounds for the treatment of metabolic disorders |
06/15/2011 | CN102099351A 3-heterocyclic substituted indole derivatives and methods of use thereof |
06/15/2011 | CN102099340A Heterocyclic compounds as factor IXA inhibitors |
06/15/2011 | CN102093751A Pigment particle dispersion body, photo-curing composition and color filter using dispersion |
06/15/2011 | CN102093369A Method for extracting chlorophyll and preparing sodium ferrous chlorophyll from silkworm excrement |
06/15/2011 | CN102093368A Preparation method of chlorophyll ketonic acid salt |
06/15/2011 | CN102093367A Preparation method of spiro quaternary ammonium salt for organic electrolyte of super capacitor |
06/15/2011 | CN102093366A Bicyclo-amino pyrazol compound and application of bicycle-amino pyrazol compound in resisting coxsackie virus |
06/15/2011 | CN102093365A Method for producing 4-hydroxy-6-methyl-1,3,3a,7-tetraazaindene |
06/15/2011 | CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor |
06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
06/15/2011 | CN102093245A Preparation method of sitagliptin intermediate, sitagliptin or salts thereof |
06/15/2011 | CN101817825B Bi-dihydroxy ethylene urea, derivatives, preparation method and application thereof |
06/15/2011 | CN101596191B Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
06/15/2011 | CN101550140B Method and apparatus for synthesis of tetaraary porphyrin |
06/15/2011 | CN101418002B Conjugated dendritic electrically-induced pure red material and preparation method and use thereof |
06/15/2011 | CN101124228B Pyrazolopyrimidine compounds as antitumor agents |
06/15/2011 | CN101072778B Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
06/14/2011 | USRE42462 Carboxylic acid derivatives, their preparation and use |
06/14/2011 | US7960725 Aryl-aryl dendrimers |
06/14/2011 | US7960560 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione |
06/14/2011 | US7960409 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents |
06/14/2011 | US7960407 Crystal forms of an imidazole derivative |
06/14/2011 | US7960400 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
06/14/2011 | US7960398 Potent inhibitors of TNF activity |